Paul W. Franks
Affiliations: | Philosophy | Yale University, New Haven, CT |
Area:
Religious StudiesGoogle:
"Paul Franks"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Franks PW. (2023) Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk. Diabetes Care. 46: 916-917 |
| Coral DE, Fernandez-Tajes J, Tsereteli N, et al. (2023) A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes. Nature Metabolism |
| Li JH, Perry JA, Jablonski KA, et al. (2022) Identification of Genetic Variation Influencing Metformin Response in a Multi-Ancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP). Diabetes |
| Merino J, Guasch-Ferré M, Li J, et al. (2022) Polygenic scores, diet quality, and type 2 diabetes risk: An observational study among 35,759 adults from 3 US cohorts. Plos Medicine. 19: e1003972 |
| Maxwell TJ, Franks PW, Kahn SE, et al. (2022) Quantitative trait loci, G×E and G×G for glycemic traits: response to metformin and placebo in the Diabetes Prevention Program (DPP). Journal of Human Genetics |
| Pervjakova N, Moen GH, Borges MC, et al. (2022) Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Human Molecular Genetics |
| Chen J, Spracklen CN, Marenne G, et al. (2021) The trans-ancestral genomic architecture of glycemic traits. Nature Genetics |
| LI JH, PERRY JA, JABLONSKI KA, et al. (2021) 28-OR: Identification of Ancestry-Specific Alleles in a Genome-Wide Association Study (GWAS) for Metformin (MET) Response in the Diabetes Prevention Program (DPP) Diabetes. 70 |
| Cai L, Wheeler E, Kerrison ND, et al. (2020) Genome-wide association analysis of type 2 diabetes in the EPIC-InterAct study. Scientific Data. 7: 393 |
| García-Calzón S, Perfilyev A, Martinell M, et al. (2020) Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes. Science Translational Medicine. 12 |